PFAPA syndrome is an autoinflammatory condition that causes recurring, predictable episodes of high fever in young children, along with mouth sores, sore throat, and swollen neck lymph nodes. The name is an acronym for its hallmark features: Periodic Fever, Aphthous stomatitis (mouth ulcers), Pharyngitis (throat inflammation), and Cervical Adenitis (swollen lymph nodes in the neck). It typically begins around age 2, and while the repeated fevers can be alarming, children grow and develop normally between episodes and the condition resolves on its own in most cases.
The Fever Pattern That Defines PFAPA
The most distinctive feature of PFAPA is how regular the fevers are. Episodes last 3 to 6 days and recur every 3 to 8 weeks, often with clockwork precision. Parents frequently report being able to predict the next episode on a calendar. During a flare, a child’s temperature can spike to 104°F or higher, and at least one of the three cardinal symptoms appears alongside the fever: small painful mouth ulcers, a red and inflamed throat, or tender swollen lymph nodes on the sides of the neck. Some children get all three, while others consistently develop just one or two.
Between episodes, children feel completely fine. There’s no lingering fatigue, no slow decline. This “all or nothing” pattern, where a child cycles between perfectly healthy stretches and intense but short-lived fevers, is one of the clearest clues that PFAPA is behind the symptoms.
What Causes the Recurring Inflammation
PFAPA is not caused by an infection. Throat cultures come back negative, and antibiotics don’t help. Instead, the problem lies in the innate immune system, the body’s first line of defense. In children with PFAPA, a molecular complex called the inflammasome becomes overactive during flares. This triggers excessive release of a powerful inflammatory signaling molecule called IL-1 beta. Research from the journal Pediatric Rheumatology found that immune cells from PFAPA patients produced roughly 2.5 times more IL-1 beta during a fever episode than between episodes. When researchers blocked the enzyme responsible for activating IL-1 beta in lab samples, the excess production stopped, confirming that this pathway drives the flares.
No single gene has been identified as the cause. PFAPA has traditionally been considered a sporadic condition, meaning it appears randomly rather than running in families. But that view is shifting. Familial cases have been reported, and rare variants in specific genes have been found in some patients. Variants in the MEFV gene, which is linked to a related condition called familial Mediterranean fever, appear to modify how severe PFAPA episodes are. Still, no genetic test can confirm or rule out PFAPA at this point.
How PFAPA Is Diagnosed
There is no blood test or imaging scan that confirms PFAPA. Diagnosis is clinical, meaning it’s based on recognizing the pattern of symptoms over time. The median age at onset is about 1.9 years, but children often aren’t diagnosed until around age 4 because it takes several cycles for parents and doctors to recognize the pattern and rule out other causes.
The key diagnostic step is excluding conditions that look similar. Cyclic neutropenia, a rare inherited disorder, also causes fevers on a regular cycle, typically every 21 days. The crucial difference is in blood counts: during a fever episode, children with cyclic neutropenia have extremely low white blood cell counts (neutrophils below 500 per cubic millimeter), while children with PFAPA do not. Cyclic neutropenia also tends to cause more severe mouth ulcers and gum inflammation, and fevers don’t respond to a single dose of corticosteroids, which is a hallmark response in PFAPA. Other periodic fever syndromes with known genetic causes, like familial Mediterranean fever, also need to be considered and can sometimes be distinguished through genetic testing.
How Flares Are Managed
The most effective way to cut a PFAPA flare short is a single dose of a corticosteroid, typically given at the onset of fever. In most children, the fever breaks within hours. This rapid, dramatic response is so characteristic that it’s sometimes used as a diagnostic clue. However, corticosteroids come with a trade-off: while they end the current episode quickly, they can shorten the interval between episodes. Some parents find that the fevers start coming every 2 to 3 weeks instead of every 5 to 6, which means more frequent, if shorter, disruptions.
Standard fever reducers like ibuprofen and acetaminophen can help a child feel more comfortable during an episode but generally don’t shorten the flare or break the fever completely.
Tonsillectomy as a Long-Term Option
For families dealing with frequent, disruptive episodes, tonsillectomy is the most effective long-term treatment. In a study published in the Brazilian Journal of Otorhinolaryngology, 21 of 23 children (91%) experienced complete resolution of their PFAPA episodes immediately after surgery. The reason tonsillectomy works so well isn’t entirely understood, since PFAPA is an immune system disorder rather than a tonsil problem. One theory is that the tonsils serve as a site where the overactive inflammatory cycle gets triggered, and removing them breaks that loop.
Tonsillectomy is generally reserved for children whose episodes are frequent enough to significantly affect quality of life, causing missed school days, repeated emergency department visits, or high parental stress. It’s not always the first choice because the condition does resolve on its own over time.
Long-Term Outlook
PFAPA resolves spontaneously in most children before they reach adolescence. In a large follow-up study, the median age at the last fever episode was 8.3 years, with most children experiencing their final flare somewhere between ages 5 and 10. The typical total duration of illness is about 5.4 years from onset to resolution. Some studies have reported complete resolution slightly later, with mean ages around 9 to 11 years.
Importantly, PFAPA does not cause lasting damage. Children maintain normal growth and development throughout the course of the disease, and there are no known long-term complications once the episodes stop. The condition can be exhausting and stressful for families in the moment, but the overall trajectory is reassuring: it ends, and children come through it healthy.